Mesenchymal stem cells in the treatment of diabetes mellitus: perspectives
Over recent decades, diabetes mellitus remains one of the main public healthcare problems worldwide with a tendency to steady growth. Actual prevalence of only type 2 diabetes mellitus among adults (20-79 years old) in Kazakhstan was higher than it was expected and amounted to 8.2% according to the...
Saved in:
Main Authors: | Olga Ulyanova (Author), Temirlan Karibekov (Author), Galiya Shaimardanova (Author), Larissa Kozina (Author) |
---|---|
Format: | Book |
Published: |
National Scientific Medical Center,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinico-morphological characteristics of patients with systemic scleroderma before and after autologous bone marrow-derived mesenchymal stem cells transplantation
by: Natalya Krivoruchko, et al.
Published: (2018) -
Administration of Autologous Mesenchymal Stem Cell Transplantation for Treatment of Type 1 Diabetes Mellitus
by: Ensieh NASLI ESFAHANI, et al.
Published: (2015) -
Management of Type 1 diabetes mellitus with autologous mesenchymal stem cells
by: Pradeep V Mahajan, et al.
Published: (2019) -
Potential therapeutic applications of mesenchymal stem cells for erectile dysfunction in diabetes mellitus: From preclinical/clinical perspectives
by: Serap Gur
Published: (2021) -
Clinical Perspectives of Mesenchymal Stem Cells
by: Jan Kramer, et al.
Published: (2012)